August 15, 2012

The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

August 13, 2012

A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.

July 27, 2012

Men diagnosed with prostate cancer are less likely to die from the disease than from such preventable conditions as heart disease, according to a new study from Harvard School of Public Health.

July 26, 2012

Safeway has raised more than $9 million during its month-long prostate cancer awareness campaign.

June 13, 2012

Ed Randall's Fans for the Cure on Wednesday announced that it once again has teamed with Walgreens to increase awareness about prostate cancer in baseball ballparks across the United States.

June 5, 2012

Safeway and its charitable arm have launched their annual prostate cancer awareness campaign this month.

May 31, 2012

Sam's Club is marking Men's Health Month in June by offering free men's health screenings at its pharmacies.

May 23, 2012

All men know: It’s not the fall that kills you; it’s that sudden stop at the end. Men smoke more, drink more and eat more. Men die sooner and are less likely to seek health care on their own. Men are full-throttle all-systems-go, until one day they’re not. Because it’s that sudden run-in with a heart attack or stroke, that sudden diagnosis of prostate or colon cancers, that slows them down.

March 30, 2012

Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

March 23, 2012

Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

January 19, 2012

Fresh & Easy has introduced its own line of vitamins and supplements that includes 20 products.

November 21, 2011

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

October 13, 2011

New research published in the October 2011 issue of Harvard Men's Health Watch suggested aspirin may play a role in fighting cancer, the publication announced Wednesday.

October 12, 2011

A drug made by Eli Lilly & Co. produced "significant" improvements in patients with erectile dysfunction who also had benign prostatic hyperplasia, according to results of a new study.

October 12, 2011

A National Institutes of Health study published Tuesday in the Journal of the American Medical Association established a link between vitamin E supplementation and prostate cancer.

October 7, 2011

The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday.

October 4, 2011

More than three-quarters of cancer patients have insufficient levels of vitamin D, and the lowest levels are associated with more advanced cancer, according to a study presented Oct. 2 at the 53rd Annual Meeting of the American Society for Radiation Oncology.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

August 23, 2011

The Food and Drug Administration will decide whether or not to approve a new usage for a cancer drug made by Amgen by next year, the drug maker said.

August 18, 2011

Generic drug maker Sun Pharmaceutical Industries has received regulatory approval for a drug designed to treat an enlarged prostate.

August 12, 2011

Generic drug maker Mylan has begun shipping a drug for enlarged prostate, the company said Friday.

July 18, 2011

Safeway on Monday announced that its month-long prostate cancer campaign raised nearly $10.1 million as part of the company’s ongoing effort to fund research geared toward finding a cure for the leading cancer affecting men.

June 21, 2011

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

June 20, 2011

The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer.